Immunotherapy for Myasthenia Gravis | NYU Langone Health
NYU Langone specialists may administer a protein called immunoglobulin to treat severe myasthenia gravis.
Immunotherapy for Vasculitis | NYU Langone Health
Langone doctors may prescribe intravenous immunoglobulin therapy for people with more serious forms of vasculitis.
Impact of A Structured Anxiety Reduction Program on Anxiety in Patients Who Are Discharged to Home Following an Acute Stroke in an Academic Medical Center
The purpose of this research study is to determine if participating in a structured anxiety reduction program helps to decrease your experience of anxiety after suffering an acute stroke. The structured anxiety reduction program that will be offered to you is from material that is available at NYU Langone Health regularly. This research study is being done to collect your thoughts and reactions to an anxiety reduction program offered to you made up of components offered by NYU Langone health. We will do this through surveys. The surveys will include some of your personal health information and your baseline anxiety followed by your response after 3 months to the anxiety reduction program and your evaluation of the program.
IMpAct of CardiolRxTM oVer 6 months following IL-1 Blocker cessation in pERICarditis patients MAVERIC
The purpose of this research study is to evaluate if study treatment with CardiolRxTM will prevent pericarditis recurrences after the therapy when the IL-1 blocker has been stopped.
Impact of time restricted feeding in obese subjects undergoing a low-calorie diet
The impact of circadian rhythms appear to impact various biologic mechanisms including sleep, nutrition, and physical activity. We wish to understand the impact of timing of food consumption and how it may affect weight loss. Participants in the study will be undergoing a low calorie diet, and we will attempt to vary the times at which participants will eat. We will examine differences in rates of weight loss over the course of two, four and eight weeks. This will be an initial pilot study in an attempt to see if there is more effective weight loss with time restricted feeding.
Impact of Weight Loss in Patients with Hypertrophic Cardiomyopathy
This is an observational imaging study to evaluate the cardiac effects of weight loss in obese patients with a BMI >=30 with a confirmed diagnosis of hypertrophic cardiomyopathy. The sample size will be 120 patients. Based on the clinical evaluation of the NYU Langone Health Weight Management Program and on patient preference, patients will be offered either bariatric surgery or a diet and exercise regimen. Patient management before, during, and after weight loss intervention(s), including subsequent follow-up, will be in accordance to standard of care. Patients will have echocardiographic and quantitative radiographic imaging either by Cardiac MRI or ECG-Synchronized cardiac CT angiogram of the chest no more than 3 months before and again 18 months after their patient-chosen weight loss program. MRI is the preferred method of radiographic imaging while CT will be reserved only for patients who have a pacemaker or implanted cardiac defibrillator. Patients who do not complete their chosen weight loss program or those who do not lose weight by the End of Study visit will still undergo final research imaging procedures for comparison analysis.
Impella -Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
The primary objective of the PROTECT IV Trial is to demonstrate the superiority of percutaneous coronary intervention (PCI) performed with Impella mechanical circulatory support (MCS; Impella CP®, Impella CP® with SmartAssist® or Impella 2.5® devices) compared with PCI without Impella in high-risk patients with reduced left ventricular ejection fraction undergoing percutaneous intervention of complex coronary artery disease (CAD). The principal hypothesis is that by providing effective hemodynamic support in high-risk patients with reduced left ventricular systolicfunction and complex CAD undergoing high-risk PCI, Impella mechanical circulatory support will facilitate a safer procedure with higher rates of optimal and complete revascularization, which will lead to improved event-free survival, quality of life (QoL) and functional outcomes at 3-year followup.
Implantable Cardioverter Defibrillator for Ventricular Arrhythmias | NYU Langone Health
NYU Langone doctors use implanted cardioverter defibrillators to manage the symptoms of ventricular arrhythmias.
Implementing an effective Diabetes intervEntion Among Low-income immigrants (IDEAL Study)
Dr. Lu Hu and her research team at NYU Langone Health are conducting a study to evaluate the effectiveness of a culturally and linguistically tailored diabetes program designed specifically for Chinese Americans. This program aims to help participants manage their diabetes and prevent related complications. The goal of this research study is to determine whether our diabetes education program can effectively lower blood sugar levels in Chinese immigrants with type 2 diabetes Study Details: Duration: Approximately 1 year Surveys: Baseline, 6-months, 12-months Participation: Participants will be randomly assigned to one of three groups: Group 1: Receives brief mHealth diabetes education videos weekly for 24 weeks. Group 2: Receives the same weekly mHealth videos plus bi-weekly support calls from a trained, bilingual community health worker to assist with goal setting. Group 3: Control group: continues with usual care but will receive the brief mHealth diabetes education videos at the end of the study.
Improving food access in East Flatbush through a community partner coalition in New York City (NYC)
The purpose of this study is to improve food access and diet quality among the East Flatbush community by providing locally grown produce via a client-choice food pantry.